Explore the potential of SGLT2 inhibitors for IgAN. Learn how these diabetes drugs slow kidney damage progression when added to standard treatment.

Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is a rare kidney disorder—in many cases, the exact ...

Not intended for the UK Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with prima ...

Apecotrep (BI 764198) is a potential first-in-class, oral, selective TRPC6 inhibitor being investigated as a novel, targeted, non-immunosuppressive therapy in people with primary focal segmental ...

By placing the cells on surfaces patterned with fractal shapes that mimic natural structures in the kidney, the team ...

Understanding your creatinine levels is important for monitoring kidney function. When you go for your yearly check-up, you'll likely have a routine blood test for creatinine. In some ...

NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.

How would you treat a 30-year-old woman with systemic lupus erythematous (SLE) and lupus nephritis (LN) class 3 with new ...

Translational medicine researchers used the Mimetas® human kidney glomerulus-on-a-chip to investigate potential pharmaceutical interventions for patients with a severe kidney disease called focal ...

Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.

High blood pressure could do more damage than you think. A research team from the Medical University of Vienna has discovered that high blood pressure on its own can damage very important kidney cells ...